Welcome to our dedicated page for Quipt Home Medical SEC filings (Ticker: QIPT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Trying to confirm how Quipt Home Medical turns oxygen-therapy rentals into steady cash flow or when executives last bought shares? This SEC filings hub answers those exact questions investors type into search鈥攚hether it鈥檚 鈥淨uipt Home Medical SEC filings explained simply鈥� or 鈥淨uipt Home Medical annual report 10-K simplified.鈥�
Every document鈥攆rom a routine 鈥淨uipt Home Medical quarterly earnings report 10-Q filing鈥� to a surprise 8-K鈥攊s captured the moment EDGAR releases it, then decoded by Stock Titan鈥檚 AI. You鈥檒l get concise plain-English summaries, key metric extractions, and reimbursement-risk callouts without wading through footnotes. Looking for 鈥淨uipt Home Medical Form 4 insider transactions real-time鈥�? Our dashboard streams those filings live, highlights 鈥淨uipt Home Medical executive stock transactions Form 4,鈥� and lets you set alerts so nothing is missed.
Use the page to:
- Run 鈥淨uipt Home Medical earnings report filing analysis鈥� and compare respiratory equipment revenue quarter over quarter.
- Dive into 鈥淨uipt Home Medical proxy statement executive compensation鈥� to see how leadership pay tracks patient-care outcomes.
- Read 鈥淨uipt Home Medical 8-K material events explained鈥� for fast insight into acquisitions that expand the service footprint.
With AI-powered summaries, expert context, and real-time updates, our coverage of all filing types鈥�10-K, 10-Q, 8-K, and 鈥淨uipt Home Medical insider trading Form 4 transactions鈥濃�攖urns dense regulatory text into clear, actionable insight. Understand the company鈥檚 reimbursement exposure, growth strategy, and insider sentiment instantly, so you can focus on decisions, not document hunting.
Quipt Home Medical Corp. announced a press release furnished on August 11, 2025 reporting its financial results for the quarter ended June 30, 2025. The filing states the press release is furnished as Exhibit 99.1 and that the information is furnished, not filed, under the Exchange Act.
The company discloses the press release includes Non-GAAP financial measures along with GAAP comparatives and reconciliations and explains management believes these measures provide useful supplemental information. The 8-K is signed by CFO Hardik Mehta and identifies Quipt as an emerging growth company incorporated in British Columbia, Canada.
Quipt Home Medical Corp. reported results for the quarter and nine months ended June 30, 2025. Revenue for the quarter was $58.3 million, down 4.1% from $60.8 million a year earlier, and nine-month revenue was $177.0 million versus $184.6 million. The company recorded a quarterly net loss of $3.0 million (basic loss per share $0.07) and a nine-month net loss of $7.2 million (basic loss per share $0.17), both larger than the prior-year periods. Adjusted EBITDA remained positive at $13.7 million for the quarter and $41.0 million for nine months.
Quipt ended the period with $11.25 million of cash and total assets of $236.1 million against total liabilities of $133.6 million. The Company was in compliance with its senior credit facility covenants and had $66.0 million principal outstanding under that facility. Management disclosed a DOJ civil investigative demand related to CPAP claims and noted the SEC concluded its inquiry in November 2024. After period end, Quipt acquired Mediserve for approximately $2.6 million. The Company performed an interim goodwill impairment test following market declines and identified no impairment.
FAQ
What is the current stock price of Quipt Home Medical (QIPT)?
What is the market cap of Quipt Home Medical (QIPT)?
